Showing posts with label gynecologic cancer. Show all posts
Showing posts with label gynecologic cancer. Show all posts

Wednesday, December 9, 2020

Dec. 9, 2020 - The Needs of Young Adult Gyn Cancer Patients

The #gyncsm community was pleased to have the #ayacsm community join us for our chat on The Needs of Young Adult Gyn Cancer Patients. We had twenty-one participants. You may find a link to the complete transcript here and the analytics here (via Symplur). 

Note that AYA patients generally fall between 15 and 40 years of age. 

Here are highlights of the participant responses to the topic questions:

T1: Do gyn cancer symptoms present differently in the Adolescent/Young Adult (AYA) population than they do in the adult/older adult population?

  • Similar to adults : A study done in Iran 15-35 years old in #ovca abdominal or lower back pain 52%, unusual bloating, fullness and pressure in the abdomen 37%, gastro-intestinal problems 36% physio-pedia.com/images/b/b6/Ea…
  • The average age for ovarian cancer is over 50/60 but plenty of younger women get it and even children get some types. Any bleeding after menopause is a symptom that needs to get checked out for gyn cancers - so that trigger isn't there in those pre-menopause.
  • The gynecologic cancer symptoms (see table) can be easy to write off as other things, so I think both young women and doctors aren't thinking "cancer" when these symptoms arise. The whole "too young for cancer" thinking needs to go. #gyncsm #ayacsm


T2: What are some unique aspects of being diagnosed with a gyn cancer ( or any cancer) as a young adult? 

  • For me, fertility issues weren't addressed/taken seriously, and as a result, I was never able to have kids. It didn't have to be that way if any of my doctors over the years had remembered that I was young.
  • We have unique needs like fertility, family planning, dating, sexual health, college/education, and long term side effects.
  • I would think that #fertility would be a big issue 
  • For me it was feeling like I didn't really fit in. The younger women with ovarian cancer typically had a different type than me. Most of the women with high grade serous are 20 years older than me.
  • Isolation is HUGE for AYA’s! I have experienced it myself. It’s difficult when you don’t see your peers in the waiting room or support groups. 
  • Young women have unique roles that do not mesh well with cancer treatment. Work, life, childcare. Women are used to being the caregivers in their family and having cancer is a role reversal that is very difficult. 

T3: How soon should AYA patients, or in some cases their parents, initiate a conversation with their oncologists about fertility?

  • Fertility is a critical issue for #AYA pts with #gynecologiccancer no matter where the woman is in her journey- it should be discussed early and plans made! 
  • Right away! Elicit the care of an #oncofertility specialist so you can make plans and protect and preserve your fertility if possible 
  • Fertility should be discussed at diagnosis with anyone diagnosed with a gynecologic malignancy during their reproductive years. Nearly all treatment disrupt fertility.
  • I am working towards a world where it is brought up by the care team at the very *first appointment*, large cancer center, or a county hospital. 
  • T3 &4 #gyncsm #ayacsm need to address also fears/myths/biases of providers, patients, & caregivers have that if we focus or address #sexaftercancer #Menopause #oncofertiliy we are not being “aggressive” about cancer treatment ; need to lay it all out good&bad early & openly.

T4: In your experience, do providers discuss and provide resources related to surgical menopause? 

  • T4 well it didn’t happen for me. Surprise! 
  • Definitely have to do better. People should get the whole story from their PROVIDERS. Good/Bad. This shouldn’t be found out afterwards or from Dr Google or from social media after the fact 
  • T4: I feel like this too often has been an "oh, by the way..." part of treatment planning. Maybe because if affects everyone so differently that it is hard to set expectations? Addressing surgical menopause is an area for improvement. 
  • Nearly all treatments for gynecologic cancer (or pre-malignancies) have the potential to initiate menopause. This has to part of the conversation with younger patients at diagnosis. 
  • I was told that a certain treatment would impact when I could get pregnant, but was never told the maintenance treatment would cause infertility. Not the same, I know... 
  • My regular ob/gyn brought it up before my gyn onc did. And I was the one intiating these discussions with my gyn onc. This is an area that I feel was definitely lacking. I felt like I needed to be guided on what it does to your body over time to go into menopause before you are supposed to. I have had to teach myself.
  • Treatment for menopausal symptoms is underprescribed - estrogen or other therapies may be safe. Ask your care team for your options. 
  • T4 Not nearly often enough, from what our @CancerHopeNet clients tell us. Orgs like @ElephantsTea are doing good work to raise awareness and reduce reluctance to discuss openly. 
  • T4 Some great resources for menopause @WomanLab_ @stacylindau @drmonicaxmas

T5: Are special support programs in place to help AYA? What about support from other AYA patients specifically?  

T6: What roadblocks exist and what advice would you give to AYA regarding sharing their diagnosis with others - when looking for higher education, employment, dating, etc? 

  • Ask for help! We will help you find resources. 
  • T6: In my opinion: getting AYA as a community and group recognized by the entire oncology community. I think that’s the biggest step to getting AYA’s resources no matter where they are. 
  • Don't be afraid to ask - especially the "older" survivors. I've found many were around my age at the time of diagnosis and they've been there, done that, SURVIVED that, *and* have the t-shirt.
  • For career and/or legal related items, @CancerAndCareer and @TriageCancer are good resources.
  • Orgs like @CancerHopeNet can provide matches based on age/dx/circumstances as well.

#gyncsm will be “off” in January. We look forward to chatting again on Wed, Feb 10, 2021 at 8pmET when we’ll discuss “Communication with your health care team and Asking for Supportive Care”. All welcome. 

Please note our new time to meet in 2021. 


Wishing the #gyncsm community a very Happy Holiday and a safe, healthy and Happy New Year! 


See you in 2021!

Dee 

Additional Resources

https://www.cancer.gov/types/aya via @theNCI

Livestrong  

Teenage Cancer Trust 

Ovarian Cancer in Young Women 

Ovarian Cancer Among Adolescents and Young Adults

Quality of life, lifestyle behavior and employment experience: A comparison between young and midlife survivors of gynecology early stage cancers 
 
Cancer Related Distress in Young Adults Compared to Middle-Aged and Senior Adults

Thursday, December 3, 2020

The Needs of Young Adult Gyn Patients - Dec. 9, 2020

 

This month on Wednesday, December 9, 2020 at 9pm ET we join together with #ayacsm co-founders, Emily Drake (@EK_Drake), cancer researcher, and Bill Paymaster (@ukfann00) of Hope For Young Adults with Cancer (@Hope4YAWC) to discuss The Needs of Young Adult Gyn Cancer Patients. It is important that adolescent and young adult patients receive age-appropriate supportive care. 

We will be using these topic questions to lead our discussion:

T1: Do gyn cancer symptoms present differently in the Adolescent/Young Adult (AYA) population than they do in the adult/older adult population?

T2: What are some unique aspects of being diagnosed with a gyn cancer as a young adult?  

T3: How soon should AYA patients, or in some cases their parents, initiate a conversation with their oncologists about fertility?

T4: In your experience, do providers discuss and provide resources related to surgical menopause? 

T5: Are special support programs in place to help AYA? What about support from other AYA patients specifically?  

T6: What roadblocks exist and what advice would you give to AYA regarding sharing their diagnosis with others - when looking for higher education, employment, dating, etc? 

For more information on Adolescent and Young Adults with Cancer visit:

We look forward to having you join us Wednesday on Twitter.  

Dee and Christina

#gyncsm Co-Founders

Wednesday, April 8, 2020

April 8, 2020 Open Mic on COVID19

Thank you to everyone who joined us tonight for our Open Mic chat on COVID-19.

We were happy to have the co-chairs of the SGO COVID-19 Task Force, gyn-oncologists Amanda Nickles Fader, MD (@amandanfader), Joshua Kesterson, MD (@KestersonJoshua), Bhavana Pothuri, MD, MS (@BPothuri) and patient advocate and Task Force member Annie Ellis (@stigetta) join us for this important discussion. 

You may find the transcript here and the analytics here.

We covered a number of different areas related to COVID-19 and the gyn cancer patient experience. 

Concerns and Difficulties  

  • I’m having a really hard time deciding whether to go for my next blood test and then infusion during COVID-19 risk. I skipped one infusion already
  • I am concerned about surgery delays in light of COVID 19
  • Every surgical procedure potentially exposes the patient and a dozen HCW to #COVID19. #PPE is still an issue in many places. And access to testing has been an issue as well.
  • Not too bad since doing chemo gave a taste of isolation. But i miss going outside to stay active 
  • Many lynch syndrome patients get annual tests, especially colonoscopies, so having them put off by even a few months can be stressful 
  • The human connection is so important and what I love about caring for patients. With social distancing, it is challenging. 


SGO Task Force - Guidelines and Care

  • @SGO_org COVID-19 Task Force has been working around the clock to develop strategies for doctors to continue to provide the very best care possible to their patients during these difficult times 
  • Goal is to keep patients safe and in this current crisis, that involves avoiding an infection with no cure. SGO COVID 19 Task Force developing guidelines so no patients left behind/forgotten.
  • The SGO COVID-19 Task Force guidelines are specific for GYN cancers. https://www.sgo.org/clinical-practice/management/covid-19-resources-for-health-care-practitioners/
  • Hang in there! Cancer care is still being prioritized, but changes are being made to minimize patients' risk of exposure - especially important as we recognize that cancer patients may be at high risk for becoming quite ill from COVID-19. 
  • Please understand that you all are very important and we are making the best decisions we can during this time of greater infection risk and increased resource limitations. Thank-you for your patience and understanding #COVID19 #GYNcsm #SGOCOVID19


Treatment / Follow-up Care

  • Depends on how you are feeling and what your treating #MD thinks whether risks are greater than benefit; These are hard decisions and need to be individualized.
  • I think the issue is that we don't know how long this is going to last - and we certainly want to keep you on track for your treatment. It's a difficult decision 
  • Agree they can be stressful, but know it is more risky to come in now for a screening test.
  • Delays in cancer screening and health check ups should only be temporary. Trying to balance risks of medical care with exposures to COVID-19. 
  • Yes in high #COVID burden areas this is the case. But even in these areas we are able to do cases that we deem are necessary. Working hard to maintain care so it does not impact outcomes. 

Telemedicine

  • But telemedicine allow us to keep very close tabs and communicate regularly with our cancer survivors. 
  • Agree, @temkins. Telemedicine is a great alternative to deliver care for our patients and cancer survivors. 
  • Something good has to come out of the COVID crisis and telemedicine and the improved patient access and convenience is going to be one of those positives.
  • Hope we will also see sustainable improvement in accessibility of second opinions with reimbursement for televisits. 
  • Telemedicine is one option but there are different laws/regulations across states 
  • This is important! We are limited in #telehealth by regulations - we need legislators to learn from this issue and expand our ability to provide care across state lines 
  • Language differences are also a challenge; interpreting clinic appointments is often challenging baseline, still need to find more #equitable solutions in order for telemedicine to not create/increase disparities imo 

Disparities

  • As we hear more about the rates of infection/deaths of African Americans with COVID19, I worry we will continue to be excluded from clinical trials due to existing comorbidities.
  • #clinicaltrials are the key to innovation in oncology and enrolling a representative patient population is good science. 
  • I hope this COVID crisis draws attention to the disparities in outcomes for African-Americans as well as based on economic status, geographic location, etc. and serves as a call for equality for all
  • In light of the high mortality rates, the financial health disparities will also become a factor as they will be faced with paying for costs of burial for those without insurance.
  • And no, we shouldn’t wait to address this when it’s all over, as some suggest. We should tackle it now. We should recognize there are certain communities that are in greater need for resources, testing, access now. Should not accept these worse outcomes are inevitable. 

Genetics Counselors

  • Genetic counselors across U.S. have been shifting our clinics to telephone/video & finding creative work-arounds to help patients access recommended genetic testing; we're doing our best to keep everyone safe, but missing in-person support of patients & families 


Support 


Survey 

Patient survey: Any person w/ #ovariancancer #fallopiancancer or #peritonealcancer is invited to complete this survey from research advocate @Stigetta on survivors' experiences during the COVID-19 pandemic. https://www.surveymonkey.com/r/OvcaCV19



Additional resources shared during the chat may be found at the end of this blog. 

Save the date for our next #gyncsm chat: 
Wed May 13, 2020 9pmET .
Topic: Side effects of Surgery

We'll end this blog with Tweets from two participants. 

I want to give the biggest of thanks to all the health care providers and medical staff. You guys are amazing each and every day! In Irish, thank you is “go raibh maith agat” which means “may you have goodness” I wish all the goodness for you! ❤️ 

Please spread the word to stay home to #flattenthecurve #GYNcsm #SGOCOVID19

Wishing wellness and safety for all,

Dee and Christina 


OTHER RESOURCES SHARED:
Covid19 resources for gyn cancer patients: Foundation for Women’s Cancer @GYNcancer
https://www.foundationforwomenscancer.org/news-stories/covid-19/
https://www.foundationforwomenscancer.org/covid-19-helpful-resources/

Questions? Comments? Concerns? for @SGO_org & @GYNCancer? You can leave a post FWC’s Facebook page! https://www.facebook.com/foundationforwomenscancer/

The @SGO_org website is a great resource for #COVID19 
https://www.sgo.org/clinical-practice/management/covid-19-resources-for-health-care-practitioners/ 

Covid19 webinars this week for cancer patients
Join @CancerAdvocacy Thursday, April 9, Noon ET: https://register.gotowebinar.com/register/3253972083140234252 
Join @SHAREing and @GYNCancer on Friday, April 10 at 2pm ET https://register.gotowebinar.com/register/8945691880708190222 #gyncsm

@DrMarkham- What People With Cancer Need to Know
https://www.cancer.net/blog/2020-04/coronavirus-and-covid-19-what-people-with-cancer-need-know on @CancerDotNet

@SHAREing COVID-19 Updates for Gynecologic Cancer Patients
https://www.youtube.com/watch?v=5z4umo0VYLc&feature=youtu.be

@FacingOurRisk has put out some great resources: 
Coping with Hereditary Cancer During the COVID-19 Pandemic
https://www.facingourrisk.org/about-us/about/covid-19.php 
A second helping of stress: Coping with hereditary cancer during the COVID-19 pandemic - register to view https://register.gotowebinar.com/recording/4410816644974202125 

@CancerAdvocacy Coronavirus and Cancer Resources for Survivors 
https://www.canceradvocacy.org/blog/coronavirus-cancer-resources-for-survivors/?mc_cid=d94d24cb7d&mc_eid=14aaa5ca15 

How long is it safe to delay gynecologic cancer surgery? By @RobinsonRossiGO 
https://www.mdedge.com/chestphysician/article/219514/coronavirus-updates/how-long-it-safe-delay-gynecologic-cancer-surgery/page/0/1 

Practicing self-care during the Time of Coronavirus @JBBC for @power4patients
 https://powerfulpatients.org/2020/03/24/practicing-self-care-in-the-time-of-coronavirus-how-to-mind-your-mental-health-and-well-being-during-covid-19/ #gyncsm #patientchat

Livestrong @livestrong Tips and Tools for living with Cancer during Covid-19 
https://blog.livestrong.org/tips-tools-for-living-with-cancer-during-covid-19-7c1ac49ea260?gi=f945388c302f

International Gynecologic Cancer Society @IGCSociety 
https://igcs.org/covid-19/

Here's what the FDA has to say so far re: clinical trials during COVID 19 
https://www.fda.gov/regulatory-information/search-fda-guidance-documents/fda-guidance-conduct-clinical-trials-medical-products-during-covid-19-pandemic?utm_source=&utm_medium=&utm_campaign= 

For AYA’s, check out @ElephantsTea ‘s #COVID19 resource page https://www.elephantsandtea.com/covid-19/
I love @DansHouseofHope, @LacunaLoft, and @MDAndersonNews Cancer 180 program also for additional resources! 

@CancerDotNet Coronovirus info
https://www.cancer.net/blog/tags/coronavirus

OCRA Covid19 info for ovarian cancer patients
 https://ocrahope.org/patients/information-on-covid-19-for-ovarian-cancer-patients/



Saturday, April 4, 2020

Open Mic on Covid-19


With the ongoing global coronavirus pandemic, we decided to "host" an Open Mic on Covid-19 instead of our original April topic about communicating with your health care professionals. We hope to host a chat on that topic later this year.

We know from our interactions on Twitter, Facebook and other patient platforms that gynecologic cancer patients and survivors have concerns about risks and questions about how Covid-19 will impact their care. From delaying a port flush or follow-up scan to delaying treatment. Women are also wondering about clinical trial participation in the ever changing Covid-19 environment.

We are excited that the co-chairs of the SGO COVID-19 Task Force - gyn-oncologists Amanda Nickles Fader, MD (@amandanfader), Joshua Kesterson, MD (@KestersonJoshua), and Bhavana Pothuri, MD, MS (@BPothuri), and patient advocate Annie Ellis (@stigetta), will be joining us on Wednesday, April 8, 2020 at 9pm ET.


Please join us as we gather to share about Covid-19 and those impacted by gyn cancers. Bring your questions and share what's on your mind:
  • What are your greatest concerns surrounding the Covid-19 pandemic?
  • Has Covid-19 impacted your treatment and follow-up care? 
  • Have you used Telemedicine to communicate with your health care provider? 
  • Is being a gyn cancer patient/ survivor putting you at increased risk for Covid-19?
  • Has clinical trial enrollment / participation been impacted during the Covid-19 outbreak? 
  • What measures have you taken to reduce the emotional issues related to the Covid-19 outbreak?
  • Where can you find the best online support and information available for cancer patients related to Covid-19? 
  • What can the #gyncsm community do to help patients and healthcare providers through this difficult time?
We look forward to being able to spend time with each other while sharing important resources. See you Wednesday.

Dee
#gyncsm Co-Founder

Wednesday, August 9, 2017

August 9,2017 Chat: "You never heard of Primary Peritoneal Cancer or GTDisease?"

This month we were pleased to raise awareness and provide information on two rare gynecologic diseases - primary peritoneal cancer (PPC) and GTD (Gestational trophoblastic disease).

We had 43 people participate in the chat with a total of 1.56 impressions and 370 tweets in the hour. You may find more stats here and the complete transcript here via Symplur. 

Below you may read some of the tweets shared in answer to our topic questions. For complete information please read the transcript or check the Resources at the end of the post. 
 
T1: What is Primary Peritoneal Cancer (PPC)? Why is it treated like ovarian cancer?
  • The peritoneum is a thin membrane that forms the lining of the abdomen. It covers all of the organs within the abdomen.
  • PPC arises is in the peritoneum (lining of the abdomen). It responds to a similar combo of surgery and chemo used for ovar ca
  • PPC is often diagnosed at stage III/IV but can still be completely cleared in the upfront setting
  • The histology (cell type) of PPC is same as #ovariancancer and Fallopian tube
  • And genetically the same as well. Also the same proteins are on the cell surfaces.
  • The most common cell type of PPC, serous carcinoma, is also the most common cell type in #ovariancancer
  • Important fact - a woman can get Primary Peritoneal Cancer even if her ovaries have been removed.
  • PPC most commonly treated like epithelial ovarian cancer w/ surgery and chemo. NCCN guidelines: https://www.nccn.org/patients/guidelines/ovarian/index.html
  • The only way to distinguish PPC vs. #ovariancancer is by path looking at the ovarian surface & stroma to see where cancer arises


T2: Are there risk factors and symptoms of Primary Peritoneal Cancer (PPC)? Is there a known genetic mutation that increases risk?

  • #BRCA mutation can put pts at risk for PPC - even if the ovaries have been removed
  • Primary #peritonealcancer in #BRCA carriers after prophylactic bilateral salpingo-oophorectomy #gyncsm ncbi.nlm.nih.gov/pmc/articles/P…
  • The symptoms & Risk factors are the same for #PrimaryPeritoneal & Ovarian cancer
  • Risk factors for PPC are the same as #ovariancancer - significant exposure to estrogen - early menarche, late menopause
  • The major risk factor for Primary Peritoneal Cancer is advancing age. #gyncsm
  • PPC symptoms are more commonly gastrointestinal - abdominal bloating, changes in bowel habits, and an early feeling of fullness.
  • Like #ovariancancer, no effective screening for PPC
  • Risk of PPC in BRCA positive patients following risk reducing BSO surgery is 1-3% in most studies
  • All women w/ invasive epithelial PPC meet guidelines for genetic counseling & testing, just like ovarian cancer


T3: What is Gestational trophoblastic disease (GTDisease)? What types of GTDisease are there? Are they all malignant? 

  • Normal cells of the placenta, called trophoblast cells,
  • a group of diseases from abnormal proliferation of trophoblasts-- these are cells from the placenta
  • GTDisease is a group of rare diseases in which abnormal trophoblast cells grow inside the uterus after conception. #gyncsm
  • Most GTD is not cancer and does not spread, but some types become cancer and spread to nearby tissues or distant parts of the body
  • GTD buff.ly/2vkVH9e GTD: -Hydatidiform -Invasive Mole -Choriocarcinoma -Placental trophoblastic tumor -Epithelioid
  • Molar pregnancy, persistent mole, invasive mole choriocarcinoma .. most need only a D and C. Some need chemo.…


T4: What are the risk factors and other important things to know for GTDisease? Is there a known genetic mutation that raises risk? 

  • Important to know: About 1/2 from molar pregnancies, 1/4 from miscarriages or ectopic and 1/4 from normal or preterm pregnancies 
  • Invasive GTN characterized into high risk and low risk subgroups which determines adjuvant chemotherapy
  • GTDisease treatments include surgery (removing tumor only or hysterectomy), chemo and radiation
  • Main GTDisease Risk: Age and previous molar pregnancy. Symptoms include abnormal vaginal bleeding and a larger than normal uterus.
  • There's not known genetic mutation related to GTDisease. A family history of molar pregnancy has been found in rare cases.
  • Ethnicity (Asian) also plays a role in GTD
  • Also important to get chest CT. About 40% will have micrometastases to the lungs that were negative on chest x-ray


T5: Are there any special support services for these two rare cancers? Where can people learn more? 


#gyncsm is joining the #Dazzle4Rare campaign August 13-19. Learn more about rare diseases and share your own story (https://www.daycause.com/hesaonlineorg/dazzle4rare-2017 )


We hope you will join us next month on Wednesday, September 13, 2017 at 9pm ET for our chat A balanced life- advocacy, survivorship, new normal. And continue this discussion rare diseases on Smart patients at https://www.smartpatients.com/partners/gyncsm 

Dee
Co-moderator #gyncsm Chat

RESOURCES: 

Primary Peritoneal Cancer

NCCN Guidelines for OC and PPC - https://www.nccn.org/patients/guidelines/ovarian/index.html

Primary Peritoneal Cancer in BRCA carriers after prophylactic bilateral salpingo-oophorectomy
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4922728/

@gyncancer Primary Peritoneal Disease Information : http://www.foundationforwomenscancer.org/types-of-gynecologic-cancers/primary-peritoneal/

PPC from Macmillan UK http://www.macmillan.org.uk/information-and-support/primary-peritoneal-cancer

PPC information Medscape http://emedicine.medscape.com/article/2156469-overview

Peritoneal Cancer Clinical Research Trials @CenterWatch https://www.centerwatch.com/clinical-trials/listings/condition/553/peritoneal-cancer

Goodman :Incidence of Ovarian, Peritoneal, and Fallopian Tube Carcinomas in the United States, 1995–2004 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2706690/)


GTD

Gestational Trophoblastic Disease Treatment (PDQ®)–Patient Version via @theNCI https://www.cancer.gov/types/gestational-trophoblastic/patient/gtd-treatment-pdq#section/all

Patient Information on Gestational Trophoblastic Disease from @gyncancer http://www.foundationforwomenscancer.org/types-of-gynecologic-cancers/gestational-trophoblastic-disease-gdt/

What is GTD American Cancer Society https://www.cancer.org/cancer/gestational-trophoblastic-disease/about/what-is-gtd.html

Gestational Trophoblastic Disease via @CancerDotNet http://www.cancer.net/cancer-types/gestational-trophoblastic-disease